Key Capabilities
The collective capabilities of Alberta’s clinical trial assets are vast. Industry sponsors frequently rely on our capabilities across a range of trial types, therapeutic areas and sectors to enable high-impact research and advance commercialization efforts. From early phase studies requiring bioanalytical support, pharmacokinetic modeling and simulation to phase IV studies involving outpatient facilities and real-world evidence, it’s possible in Alberta.
Preclinical and Early Stage Trials
Industry sponsors conducting preclinical or first-in-human early phase trials will find that Alberta boasts extensive capabilities for the effective evaluation of drug candidate safety and efficacy. Our network of facilities and support teams offer a full range of services, enabling the collection of high-quality data to inform future trials faster.
Dedicated resources for early phase trials are available to help industry sponsors advance drug candidates through our two state-of-the-art Phase I Clinical Trial Units (both housed within world-class hospitals) that enable the safe study of compounds in critical care settings.
EMRs for a population of more than 4 million
Toxicology and pathology expertise
Dedicated pre-clinical and early phase facilities
Regulatory expertise
Phase II, III and IV Trials
Industry partners from around the world rely on Alberta’s extensive late-stage trial capabilities to accelerate development efforts. Our province is home to leading institutional expertise across a range of therapeutic areas, state-of-the-art imaging and testing facilities and robust health data repositories.
In addition, outpatient research facilities can be found in both urban and rural regions across the province.
Expertise across a range of therapeutic areas
Ethnically diverse population
Real-world evidence capabilities
Full suite of trial support services
Clinical Trial Management
Industry partners conducting clinical trials in Alberta have access to a network of AROs, CROs and operational teams that provide expert support at every stage. Whether you’re seeking to address specific operational challenges or require a complete trial management solution, Alberta’s resources can provide the complementary services needed to accelerate your trials.
Trials conducted in Alberta are managed using the OnCore Clinical Trial Management System, ensuring effective oversight and reporting of all study activities from planning through closure and regulatory submission.
Concept/study development
Site identification and recruitment
Study execution and management
Regulatory compliance
Biotech Trials
Alberta is recognized as a global leader in leading and managing biotech clinical trials. Driven by our unique infrastructure and sector expertise, hundreds of biotech partners are currently engaged in trials across a range of therapeutic areas including oncology, infectious diseases, rare diseases, and genetic disorders.
Alberta also holds specific value as a trial destination for smaller biotech organizations that may not have the full spectrum of resources required to bring interventions to market. Numerous AROs and CROs offer a range of services, while a highly trained research workforce ensures that data obtained is of the highest quality (and acceptable by major regulatory bodies).
Dedicated labs and facilities
Highly skilled research workforce
Key opinion leaders
Study closure and commercialization
Health Data and Analytics
Alberta is home to one of the most robust, integrated and accessible health data repositories in the world. All of our province’s medical records (covering a population of more than 4 million) are electronic, allowing for streamlined access to high quality data that can support feasibility studies, longitudinal monitoring for regulatory approvals and pragmatic clinical trials.
Data is collected and connected from numerous sources including hospitals, primary care clinics and non-emergency health care settings.
EMRs for a population of more than 4 million
Data linkage and analytics platforms
Real-world evidence capabilities
Ability to access data remotely
Key Alberta programs and initiatives
In collaboration with the provincial government, a number of academic and research organizations have introduced initiatives to position Alberta as an even more attractive destination for conducting clinical trials. These include initiatives to improve start-up times, enhance patient recruitment, centralize trial management and enable access to high-quality medical data.
Be The Cure
Be the Cure is a provincial awareness campaign designed to educate Albertans about the importance of participating in clinical trials. Running for over five years, the campaign has reached across the province to create an engaged and informed population that understands the importance of clinical research. In addition, the associated health research database easily connects patients with research opportunities. As a result, Alberta has higher rates of participant uptake and faster trial recruitment timelines when compared to other provinces.
Learn More
Connect Care
Connect Care is Alberta’s singular electronic medical records system, containing integrated health data for the entire provincial population (more than 4 million people). Based on the EPIC platform, this centralized system provides numerous advantages, including streamlined access to robust medical data, enhanced recruitment capabilities, and the ability to remotely monitor clinical trials conducted in the province.
OnCore Clinical Trial Management System
The University of Calgary, the University of Alberta, and Alberta Health Services have jointly adopted the new provincial Clinical Trial Management System (CTMS). The OnCore CTMS enhances Alberta’s clinical trial infrastructure by increasing efficiencies in trial management. The new system enables increased capacity for additional studies, standardization and adoption of best practices, and improved study quality, budget management, and regulatory compliance because of automated processes.
Learn more
REB Exchange
The REB Exchange is an innovative technology platform that enables a single provincial ethics review for multi-site research conducted in Alberta. By providing a centralized, singular point of submission, the REB Exchange reduces study costs and increases efficiency by helping avoid duplication during the submission process, ensuring high quality reviews, and shortening study start-up times. It also allows for more efficient methods of reporting serious adverse events and reduces the need to engage multiple local research ethics boards.
Learn More
Take your clinical trial to Alberta
Alberta is positioned as the premier destination for conducting high-quality clinical trials. To learn more about taking your next clinical trial to Alberta, or to connect with an Alberta investigator to further your research, contact us.